Aspire Private Capital’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-400
| Closed | -$1.22K | – | 431 |
|
|
2024
Q3 | $1.22K | Hold |
400
| – | – | ﹤0.01% | 583 |
|
|
2024
Q2 | $1.11K | Hold |
400
| – | – | ﹤0.01% | 592 |
|
|
2024
Q1 | $1.45K | Hold |
400
| – | – | ﹤0.01% | 603 |
|
|
2023
Q4 | $500 | Hold |
400
| – | – | ﹤0.01% | 644 |
|
|
2023
Q3 | $399 | Hold |
400
| – | – | ﹤0.01% | 646 |
|
|
2023
Q2 | $292 | Hold |
400
| – | – | ﹤0.01% | 629 |
|
|
2023
Q1 | $1.09K | Hold |
400
| – | – | ﹤0.01% | 566 |
|
|
2022
Q4 | $984 | Hold |
400
| – | – | ﹤0.01% | 562 |
|
|
2022
Q3 | $1K | Hold |
400
| – | – | ﹤0.01% | 573 |
|
|
2022
Q2 | $1K | Hold |
400
| – | – | ﹤0.01% | 557 |
|
|
2022
Q1 | $1K | Hold |
400
| – | – | ﹤0.01% | 555 |
|
|
2021
Q4 | $2K | Buy |
+400
| New | +$2K | ﹤0.01% | 526 |
|